Importance of high radiation doses (72 Gy or greater) in the treatment of Stage T1-T3 adenocarcinoma of the prostate
Authors:
- Patrick A KupelianPKPatrick A Kupelian
- Dasarahally S MohanDMDasarahally S Mohan
- Chandana A ReddyCRChandana A Reddy
- Eric A KleinEKEric A Klein
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- IMPROVEMENT IN OVERALL SURVIVAL FOR PATIENTS WITH LOCALIZED PROSTATE CANCER WITH HIGHER THAN STANDARD RADIATION DOSESJournal of Urology, 1999
- Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directionsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Androgen ablation in addition to radiation therapy for prostate cancer: Is there true benefit?Seminars in Radiation Oncology, 1998
- External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up?Urology, 1998
- External beam radiotherapy dose response of prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997
- Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy aloneInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997
- Conventional vs. conformal radiotherapy for prostate cancer: Preliminary results of dosimetry and acute toxicityInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology groupUrology, 1995